207 related articles for article (PubMed ID: 11443641)
1. Antibody against platelet membrane glycoprotein VI in a patient with systemic lupus erythematosus.
Takahashi H; Moroi M
Am J Hematol; 2001 Aug; 67(4):262-7. PubMed ID: 11443641
[TBL] [Abstract][Full Text] [Related]
2. A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion.
Moroi M; Jung SM; Okuma M; Shinmyozu K
J Clin Invest; 1989 Nov; 84(5):1440-5. PubMed ID: 2808700
[TBL] [Abstract][Full Text] [Related]
3. [Collagen adhesion-aggregation abnormality (2nd report)--congenital platelet membrane glycoprotein VI deficiency].
Shinmyozu K; Kuriyama M; Okadome T; Maruyama Y; Maruyama I; Osame M
Rinsho Ketsueki; 1990 May; 31(5):660-4. PubMed ID: 2168494
[TBL] [Abstract][Full Text] [Related]
4. Platelet unresponsiveness to collagen: involvement of glycoprotein Ia-IIa (alpha 2 beta 1 integrin) deficiency associated with a myeloproliferative disorder.
Handa M; Watanabe K; Kawai Y; Kamata T; Koyama T; Nagai H; Ikeda Y
Thromb Haemost; 1995 Mar; 73(3):521-8. PubMed ID: 7667837
[TBL] [Abstract][Full Text] [Related]
5. Lack of platelet response to collagen associated with an autoantibody against glycoprotein Ia: a novel cause of acquired qualitative platelet dysfunction.
Deckmyn H; Chew SL; Vermylen J
Thromb Haemost; 1990 Aug; 64(1):74-9. PubMed ID: 2274930
[TBL] [Abstract][Full Text] [Related]
6. Principal role of glycoprotein VI in alpha2beta1 and alphaIIbbeta3 activation during collagen-induced thrombus formation.
Lecut C; Schoolmeester A; Kuijpers MJ; Broers JL; van Zandvoort MA; Vanhoorelbeke K; Deckmyn H; Jandrot-Perrus M; Heemskerk JW
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1727-33. PubMed ID: 15231520
[TBL] [Abstract][Full Text] [Related]
7. Defect of platelet aggregation and adhesion induced by autoantibodies against platelet glycoprotein IIIa.
Balduini CL; Bertolino G; Noris P; Piovella F; Sinigaglia F; Bellotti V; Samaden A; Torti M; Mazzini G
Thromb Haemost; 1992 Aug; 68(2):208-13. PubMed ID: 1412168
[TBL] [Abstract][Full Text] [Related]
8. Highly potent anti-human GPVI monoclonal antibodies derived from GPVI knockout mouse immunization.
Matsumoto Y; Takizawa H; Gong X; Le S; Lockyer S; Okuyama K; Tanaka M; Yoshitake M; Tandon NN; Kambayashi J
Thromb Res; 2007; 119(3):319-29. PubMed ID: 16566959
[TBL] [Abstract][Full Text] [Related]
9. Anti-glycoprotein VI treatment severely compromises hemostasis in mice with reduced alpha2beta1 levels or concomitant aspirin therapy.
Grüner S; Prostredna M; Aktas B; Moers A; Schulte V; Krieg T; Offermanns S; Eckes B; Nieswandt B
Circulation; 2004 Nov; 110(18):2946-51. PubMed ID: 15505105
[TBL] [Abstract][Full Text] [Related]
10. Identification of human platelet glycoprotein VI-specific IgG autoantibody and its fragments.
Chu X; Hou M; Peng J; Zhu Y; Zhang F; Ji X; Wang L; Ma D
Blood Coagul Fibrinolysis; 2006 Jul; 17(5):403-7. PubMed ID: 16788317
[TBL] [Abstract][Full Text] [Related]
11. Ex vivo evaluation of anti-GPVI antibody in cynomolgus monkeys: dissociation between anti-platelet aggregatory effect and bleeding time.
Matsumoto Y; Takizawa H; Nakama K; Gong X; Yamada Y; Tandon NN; Kambayashi J
Thromb Haemost; 2006 Aug; 96(2):167-75. PubMed ID: 16894460
[TBL] [Abstract][Full Text] [Related]
12. Anti-glycoprotein VI monoclonal antibodies directly aggregate platelets independently of FcgammaRIIa and induce GPVI ectodomain shedding.
Al-Tamimi M; Mu FT; Arthur JF; Shen Y; Moroi M; Berndt MC; Andrews RK; Gardiner EE
Platelets; 2009 Mar; 20(2):75-82. PubMed ID: 19235048
[TBL] [Abstract][Full Text] [Related]
13. A familial platelet function disorder associated with abnormal signalling through the glycoprotein VI pathway.
Dunkley S; Arthur JF; Evans S; Gardiner EE; Shen Y; Andrews RK
Br J Haematol; 2007 Jun; 137(6):569-77. PubMed ID: 17539777
[TBL] [Abstract][Full Text] [Related]
14. Platelet glycoprotein VI-related clinical defects.
Arthur JF; Dunkley S; Andrews RK
Br J Haematol; 2007 Nov; 139(3):363-72. PubMed ID: 17910626
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of reduced glycoprotein VI levels on activation of murine platelets by glycoprotein VI ligands.
Snell DC; Schulte V; Jarvis GE; Arase K; Sakurai D; Saito T; Watson SP; Nieswandt B
Biochem J; 2002 Nov; 368(Pt 1):293-300. PubMed ID: 12117414
[TBL] [Abstract][Full Text] [Related]
16. Platelet glycoprotein VI: its structure and function.
Moroi M; Jung SM
Thromb Res; 2004; 114(4):221-33. PubMed ID: 15381385
[TBL] [Abstract][Full Text] [Related]
17. Design and humanization of a murine scFv that blocks human platelet glycoprotein VI in vitro.
Muzard J; Bouabdelli M; Zahid M; Ollivier V; Lacapère JJ; Jandrot-Perrus M; Billiald P
FEBS J; 2009 Aug; 276(15):4207-22. PubMed ID: 19558491
[TBL] [Abstract][Full Text] [Related]
18. [Identification of human platelet specific functional antibody and its fragments].
Chu XX; Hou M; Zhu YY; Peng J; Ji XB; Zhang F; Wang L
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3464-8. PubMed ID: 16686061
[TBL] [Abstract][Full Text] [Related]
19. Novel synthetic collagen fibers, poly(PHG), stimulate platelet aggregation through glycoprotein VI.
Inoue O; Suzuki-Inoue K; Shinoda D; Umeda Y; Uchino M; Takasaki S; Ozaki Y
FEBS Lett; 2009 Jan; 583(1):81-7. PubMed ID: 19059245
[TBL] [Abstract][Full Text] [Related]
20. Distinct roles of GPVI and integrin alpha(2)beta(1) in platelet shape change and aggregation induced by different collagens.
Jarvis GE; Atkinson BT; Snell DC; Watson SP
Br J Pharmacol; 2002 Sep; 137(1):107-17. PubMed ID: 12183336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
